Published in Acta Oncol on May 01, 2010
Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer. Prostate Cancer (2012) 0.84
Dose mapping sensitivity to deformable registration uncertainties in fractionated radiotherapy - applied to prostate proton treatments. BMC Med Phys (2013) 0.79
PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues. EJNMMI Res (2012) 0.78
Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR). Radiat Oncol (2015) 0.75
The contribution of women to radiobiology: Marie Curie and beyond. Rep Pract Oncol Radiother (2015) 0.75
Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement. Radiat Oncol (2017) 0.75
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med (2004) 32.09
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol (2009) 3.66
A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol (2003) 1.84
Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol (2011) 1.72
Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med (2006) 1.55
p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J Cell Biol (2002) 1.38
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol (2008) 1.20
DNA double strand break quantification in skin biopsies. Radiother Oncol (2004) 1.18
Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys (2002) 1.10
Invade or proliferate? Two contrasting events in malignant behavior governed by p16(INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer Res (2003) 1.02
Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features. Am J Pathol (2010) 1.02
The ribosomal grip of the peptidyl-tRNA is critical for reading frame maintenance. J Mol Biol (2008) 1.02
State-of-the-art tools for computational site of metabolism predictions: comparative analysis, mechanistical insights, and future applications. Drug Metab Rev (2007) 1.00
Clinical evaluation of multi-atlas based segmentation of lymph node regions in head and neck and prostate cancer patients. Radiat Oncol (2013) 0.98
Quantum chemistry can locally improve protein crystal structures. J Am Chem Soc (2003) 0.94
Direct effects of pure nicotine, cigarette smoke extract, Swedish-type smokeless tobacco (Snus) extract and ethanol on human normal endothelial cells and fibroblasts. Anticancer Res (2011) 0.94
Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma. AJR Am J Roentgenol (2012) 0.93
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. Crit Rev Oncol Hematol (2008) 0.93
Quantum chemical geometry optimizations in proteins using crystallographic raw data. J Comput Chem (2002) 0.92
1-methylguanosine-deficient tRNA of Salmonella enterica serovar Typhimurium affects thiamine metabolism. J Bacteriol (2003) 0.91
NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction. Acta Oncol (2011) 0.90
Investigations into shaking mink syndrome: an encephalomyelitis of unknown cause in farmed mink (Mustela vison) kits in Scandinavia. J Vet Diagn Invest (2004) 0.89
The phenotype of many independently isolated +1 frameshift suppressor mutants supports a pivotal role of the P-site in reading frame maintenance. PLoS One (2013) 0.88
Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma. Radiother Oncol (2004) 0.87
Survival in primary lung cancer potentially cured by operation: influence of tumor stage and clinical characteristics. Ann Thorac Surg (2003) 0.86
The IMRT information process-mastering the degrees of freedom in external beam therapy. Phys Med Biol (2006) 0.86
Diseases and mortality in free-ranging brown bear (Ursus arctos), gray wolf (Canis lupus), and wolverine (Gulo gulo) in Sweden. J Wildl Dis (2005) 0.86
Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression. Breast Cancer Res Treat (2005) 0.85
Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer. Prostate Cancer (2012) 0.84
Low-dose hypersensitive gammaH2AX response and infrequent apoptosis in epidermis from radiotherapy patients. Radiother Oncol (2008) 0.84
DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients. Anticancer Res (2010) 0.84
CRIM1 is localized to the podocyte filtration slit diaphragm of the adult human kidney. Nephrol Dial Transplant (2009) 0.84
Particle therapy - a next logical step in the improvement of radiotherapy. Acta Oncol (2011) 0.84
Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense. Infect Immun (2012) 0.83
Necrotizing encephalitis of unknown cause in Fennoscandian Arctic foxes (Alopex lagopus). J Vet Diagn Invest (2007) 0.83
Procalcitonin levels in community-acquired pneumonia - correlation with aetiology and severity. Scand J Infect Dis (2014) 0.81
Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients. Leuk Lymphoma (2010) 0.81
Early effects of low dose-rate radiation on cultured tumor cells. Cancer Biother Radiopharm (2003) 0.81
Proton beam therapy - do we need the randomised trials and can we do them? Radiother Oncol (2007) 0.81
Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques. Radiother Oncol (2002) 0.80
Effects of a dietary intervention on acute gastrointestinal side effects and other aspects of health-related quality of life: a randomized controlled trial in prostate cancer patients undergoing radiotherapy. Radiother Oncol (2012) 0.79
Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall. Int J Radiat Oncol Biol Phys (2010) 0.79
A comparison of patient position displacements from body surface laser scanning and cone beam CT bone registrations for radiotherapy of pelvic targets. Acta Oncol (2013) 0.78
1-[11C]-acetate PET imaging in head and neck cancer--a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning. Eur J Nucl Med Mol Imaging (2006) 0.78
Dissecting systems-wide data using mixture models: application to identify affected cellular processes. BMC Bioinformatics (2005) 0.78
Human papillomavirus (HPV), DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients. Anticancer Res (2008) 0.78
Imaging tumor perfusion and oxidative metabolism in patients with head-and-neck cancer using 1- [11C]-acetate PET during radiotherapy: preliminary results. Int J Radiat Oncol Biol Phys (2011) 0.77
Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations. Food Nutr Res (2011) 0.75
Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: a report of the REACT working group of ESTRO. Radiother Oncol (2004) 0.75
Portal dose image verification: formalism and application of the collapsed cone superposition method. Phys Med Biol (2002) 0.75
Assessing patients' perceived bother from the gastrointestinal side effects of radiotherapy for localized prostate cancer: initial questionnaire development and validation. Acta Oncol (2013) 0.75
Swedish Cancer Society radiation therapy research investigation. Acta Oncol (2002) 0.75
Has Robocop got diabetes? Diabetes Care (2004) 0.75
Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors. Bioorg Med Chem Lett (2011) 0.75
Radiation therapy dose delivery. Acta Oncol (2003) 0.75
In vitro effect of radiation, antibody to epidermal growth factor receptor and Docetaxel in human head and neck squamous carcinoma cells with mutant P53 and over-expressed EGFR. J Cancer Res Clin Oncol (2008) 0.75
Assessment of volume segmentation in radiotherapy of adolescents; a treatment planning study by the Swedish Workgroup for Paediatric Radiotherapy. Acta Oncol (2013) 0.75
"Distributed proton radiation therapy"--a new concept for advanced competence support. Acta Oncol (2006) 0.75
Sensitizing and protective substances in radiation therapy and predictive assays. Acta Oncol (2002) 0.75